|Day's Range||48.85 - 49.18|
|52 Week Range||36.81 - 50.24|
|PE Ratio (TTM)||24.73|
|Dividend & Yield||1.58 (3.22%)|
|1y Target Est||N/A|
Sanofi's Diabetes and Cardiovascular franchise reported revenues of ~1.4 billion euros in 1Q17.
Total prescriptions of Pfizer's eczema drug Eucrisa have flattened out over recent weeks as Regeneron and Sanofi's Dupixent has picked up steam.
Why Pfizer, Novartis, and Sanofi rank at the top of all dividend stocks in the generic-drug industry.